🚨 BREAKING The first drug where AI designed both... the target and the molecule has just published Phase II results in Nature Medicine. Patients with a fatal lung disease gained lung function in 12 weeks. Current treatments only slow the decline. This is different. 🧵 Here's what just happened (and why it matters for medicine). #AIDrugDiscovery #ArtificialIntelligenceshow more

🚨 BREAKING A drug just moved into Phase 3... trials that could SLOW Parkinson's disease for the first time in history. No treatment today actually stops the disease. Just symptoms. This one targets the ROOT CAUSE. Here's the science — and why it matters 🧵 #Parkinsons #Neuroscience #MedTwittershow more

BREAKING: Scientists now believe Parkinson's disease may not always... start in the brain. In many patients, it may begin in the gut — and travel to the brain via a nerve most people have never heard of. At the same time: → A new drug just reversed brain inflammation in PD patients for the first time in history. → A diabetes drug in the same class as Ozempic slowed Parkinson's motor decline in a New England Journal of Medicine trial. → Fecal transplants are producing lasting motor improvement in randomized controlled trials. None of this is making mainstream news. Here is what is actually happening outside the brain in Parkinson's research right now. 🧵show more

🚨 BREAKING Scientists may have just cracked the code... on Alzheimer's and Parkinson's — WITH ONE PILL. A drug called Buntanetap was just published in a peer-reviewed journal with Phase 3 data. Phase 3 means that we are on the verge of FDA approval. It targets the ROOT CAUSE of both diseases simultaneously. Here's what you need to know 🧵👇 #Alzheimers #Parkinsonsshow more

BREAKING: A new study published yesterday, July 1st, 2026,... in Nature Medicine adds a powerful new tool to the Alzheimer's early-detection toolkit. And it's forcing us to rethink what Alzheimer's "risk" even means. Here's what changed, and why your family history isn't the whole story. 🧵👇 #Alzheimers #Biomarkersshow more

BREAKING 🧬 Scientists just edited a gene in living... humans — and LDL "bad" cholesterol dropped by 62%. One injection. One time. No daily pills. Effects lasting 18 months. This isn't science fiction. It's a Phase 1b trial published in the NEJM this week. Here's what just happened 🧵show more

BREAKING: The FDA approved a cancer drug in 2024... that doesn't use chemotherapy. Instead, it powers up the immune cells you were BORN with. In trials, 62% of patients had all detectable cancer disappear completely. This is not hype. Here's what it actually is — and why it doesn't stop with cancer. 🧵show more

🚨 BREAKING: German researchers treated 15 severe lupus patients... with CAR-T therapy. All 15 went into complete remission. Many stopped ALL medication. Now a larger trial just confirmed it — across 3 autoimmune diseases. This might be the biggest shift in autoimmune medicine in decades. 🧵show more

BREAKING: For the first time in 100+ years, Alzheimer's... may not be permanent Scientists just reversed advanced Alzheimer's in mice by restoring brain energy balance, eliminating both plaques AND cognitive decline The drug worked in two different animal models, suggesting "this could translate to humans". Game-changing 🧠show more

BREAKING: For the first time in 100+ years, Alzheimer's... may not be permanent Scientists just reversed advanced Alzheimer's in mice by restoring brain energy balance, eliminating both plaques AND cognitive decline The drug worked in two different animal models, suggesting "this could translate to humans". Game-changing!!show more

Great news from our team to start the week:... positive Phase 2 results for a potential first-in-class medicine discovered and developed entirely in-house at Pfizer Inc.. It has the potential to work differently from anything available today, targeting three drivers of inflammation in a single treatment. This could make a real difference for millions of people living with conditions like atopic dermatitis, COPD, and asthma. We're accelerating toward Phase 3 and excited about what lies ahead. This is the kind of innovation our pipeline is built to deliver. More:show more

1/14 I just finished 2 weeks of work in... the hospital. Here’s a glimpse of what I saw. The kind of things that remind you why medicine is so good. First up: An S4 gallop you could not only hear… but see.show more

BREAKING: Harvard scientists may have just discovered why the... brain loses its fight against Alzheimer's ... and a trace mineral found naturally in your brain is at the center of it. This isn't another amyloid paper. It asks a completely different question. And the answer has been hiding in your brain all along 🧵👇show more

Israel just took a massive leap in the war... on cancer. New Phase developed a revolutionary nanotech treatment that uses specially designed nanoparticles to heat and destroy metastatic tumors from the inside, even in hard-to-reach areas, while sparing healthy tissue. The technology is already showing incredible results in clinical trials for late-stage cancer patients. This is precision medicine at the nanoscale, turning the body’s own biology into a targeted weapon against one of humanity’s deadliest diseases. From the lab to saving lives worldwide, Startup Nation at it again. Proud every single day. 🇮🇱 #StartupNation #IsraeliInnovation #Nanotech #CancerTreatment #NewPhaseshow more

🚨 SCIENTISTS MAY HAVE FOUND A WAY TO DESTROY... VIRUSES WITH SOUND Researchers in Brazil report that high-frequency ultrasound was able to physically damage and destabilize both COVID-19 and influenza viruses in laboratory experiments. Not with chemicals. Not with drugs. With vibration. The idea sounds almost futuristic: target the virus at the exact frequency where its outer structure begins to resonate… until the оболope becomes unstable and ruptures. Like an opera singer shattering glass but at the microscopic level. What makes this so fascinating is that the attack isn’t aimed at the virus’s genetics… it’s aimed at its physical structure. Its shape. Its resonance. Its mechanical weakness. If this technology continues to develop, future medicine may start combining: AI-guided ultrasound targeting non-invasive antiviral therapies precision acoustic medicine frequency-based treatments We may be entering an era where sound itself becomes a medical tool. And that changes how we think about fighting disease entirely. Follow for more future science and medical breakthroughs.show more

What if you could use #AI to find and... accurately excise the culprit cells, quantify >5,000 proteins in each, and find a cure for a life-threatening disease that has no effective treatment? That's the beginning of spatial medicine, a momentous medical advance. In the new Ground Truths Because X auto-suppresses the link, you can find it in my profileshow more

🚨 SCIENTISTS JUST DOSED THE FIRST PATIENT IN A... TRIAL TO REVERSE CELLULAR AGING IN THE HUMAN EYE. Life Biosciences has begun an FDA-approved clinical trial using cellular reprogramming to regenerate aging neurons in the optic nerve of glaucoma patients. Instead of just slowing vision loss, the goal is to actually reverse aspects of cellular aging in the eye essentially trying to make old nerve cells young again. Why this matters: • Glaucoma is one of the leading causes of irreversible blindness worldwide, caused by damage to the optic nerve • Current treatments can only slow progression they cannot regenerate lost vision • This approach uses partial cellular reprogramming (a controlled form of turning back the biological clock) • If successful, it could open the door to treating many other age-related neurodegenerative diseases The deeper implication is enormous: We may be entering an era where aging itself becomes treatable not just its symptoms. If we can safely reprogram cells in the eye, the same technology could eventually be applied to the brain, spine, and other organs. The first patient has now been dosed. This is no longer just theory. What do you think are we ready to start treating aging as a medical condition? Follow for more frontier science and longevity breakthroughs.show more

BREAKING 🚨: THIS IS THE FIRST AI SALES TOOL... THAT DOES THE WHOLE JOB. PERIOD. NOT JUST DATA. NOT JUST ENRICHMENT. NOT JUST TEMPLATES. RESEARCH, VERIFICATION, AND A PERSONALIZED COLD EMAIL IN UNDER 2 MINUTES. AUTOGTM BY EXPLEE IS WHAT THE OTHERS PRETEND TO BE.show more

Today the U.S. FDA approved our medicine – the... first and only gene therapy for genetic #hearingloss – signaling a new era where enabling 24/7 natural hearing is now possible. We are proud to make this available for free in the U.S. Read more:show more

"AI bot that's doing protein folding and literally coming... up with cures, doing personalized medicine for cancer patients... you could have the equivalent of like a GoFundMe, but on the blockchain, for people to basically be able to pay an AI bot to cure their cancer." BIOS is built for this. It generates discoveries. Bio Launchpad funds them. Biofy brings validated treatments to patients. Discovery -> funding -> product One system.show more